LncRNA AA465934 Improves Podocyte Injury by Promoting Tristetraprolin-Mediated HMGB1 DownRegulation in Diabetic Nephropathy

References

• Guilbert JJ. The World Health Report 2006: working together for health. Educ Health (Abingdon). 2006;19:385–387. doi:10.1080/13576280600937911.
   PubMedGoogle Scholar
• Scott RP, Quaggin SE. Review series: the cell biology of renal filtration. J Cell Biol. 2015;209:199–210. doi:10.1083/jcb.201410017.
   PubMed Web of Science ®Google Scholar
• Garg P. A review of podocyte biology. Am J Nephrol. 2018;47 Suppl 1:3–13. doi:10.1159/000481633.
   PubMed Web of Science ®Google Scholar
• Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002;13:3005–3015. doi:10.1097/01.asn.0000039661.06947.fd.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yan Y, Hu Q, Zhang X. LncRNA MALAT1/microRNA let-7f/KLF5 axis regulates podocyte injury in diabetic nephropathy. Life Sci. 2021;266:118794. doi:10.1016/j.lfs.2020.118794.
   PubMed Web of Science ®Google Scholar
• Wang Z, Chang Y, Liu Y, Liu B, Zhen J, Li X, Lin J, Yu Q, Lv Z, Wang R. Inhibition of the lncRNA MIAT prevents podocyte injury and mitotic catastrophe in diabetic nephropathy. Mol Ther Nucleic Acids. 2022;28:136–153. doi:10.1016/j.omtn.2022.03.001.
   PubMedGoogle Scholar
• Long B, Wan Y, Zhang S, Lv L. LncRNA XIST protects podocyte from high glucose-induced cell injury in diabetic nephropathy by sponging miR-30 and regulating AVEN expression. Arch Physiol Biochem. 2023;129:610–617. doi:10.1080/13813455.2020.1854307.
   PubMedGoogle Scholar
• Jing F, Zhao J, Jing X, Lei G. Long noncoding RNA Airn protects podocytes from diabetic nephropathy lesions via binding to Igf2bp2 and facilitating translation of Igf2 and Lamb2. Cell Biol Int. 2020;44:1860–1869. doi:10.1002/cbin.11392.
   PubMed Web of Science ®Google Scholar
• Jin J, Gong J, Zhao L, Li Y, He Q. LncRNA Hoxb3os protects podocytes from high glucose-induced cell injury through autophagy dependent on the Akt-mTOR signaling pathway. Acta Biochim Pol. 2021;68:619–625. doi:10.18388/abp.2020_5483.
   PubMed Web of Science ®Google Scholar
• Liu DW, Zhang JH, Liu FX, Wang XT, Pan SK, Jiang DK, Zhao ZH, Liu ZS. Silencing of long noncoding RNA PVT1 inhibits podocyte damage and apoptosis in diabetic nephropathy by upregulating FOXA1. Exp Mol Med. 2019;51:1–15. doi:10.1038/s12276-019-0259-6.
   Web of Science ®Google Scholar
• Yao ZT, Yang YM, Sun MM, He Y, Liao L, Chen KS, Li B. New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. Cancer Commun (Lond). 2022;42:117–140. doi:10.1002/cac2.12254.
   PubMed Web of Science ®Google Scholar
• Turner M, Díaz-Muñoz MD. RNA-binding proteins control gene expression and cell fate in the immune system. Nat Immunol. 2018;19:120–129. doi:10.1038/s41590-017-0028-4.
   PubMed Web of Science ®Google Scholar
• Hu J, Wang Q, Fan X, Zhen J, Wang C, Chen H, Liu Y, Zhou P, Zhang T, Huang T, et al. Long noncoding RNA ENST00000436340 promotes podocyte injury in diabetic kidney disease by facilitating the association of PTBP1 with RAB3B. Cell Death Dis. 2023;14:130. doi:10.1038/s41419-023-05658-7.
   PubMed Web of Science ®Google Scholar
• Liu F, Guo J, Qiao Y, Pan S, Duan J, Liu D, Liu Z. MiR-138 plays an important role in diabetic nephropathy through SIRT1-p38-TTP regulatory axis. J Cell Physiol. 2021;236:6607–6618. doi:10.1002/jcp.30238.
   PubMed Web of Science ®Google Scholar
• Ren C, Yang T, Qiao P, Wang L, Han X, Lv S, Sun Y, Liu Z, Du Y, Yu Z. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis. Mol Oncol. 2018;12:690–704. doi:10.1002/1878-0261.12192.
   PubMed Web of Science ®Google Scholar
• Jin J, Shi Y, Gong J, Zhao L, Li Y, He Q, Huang H. Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte. Stem Cell Res Ther. 2019;10:95. doi:10.1186/s13287-019-1177-1.
   PubMed Web of Science ®Google Scholar
• Yuan S, Liang X, He W, Liang M, Jin J, He Q. ATF4-dependent heme-oxygenase-1 attenuates diabetic nephropathy by inducing autophagy and inhibiting apoptosis in podocyte. Ren Fail. 2021;43:968–979. doi:10.1080/0886022X.2021.1936040.
   PubMed Web of Science ®Google Scholar
• Su PP, Liu DW, Zhou SJ, Chen H, Wu XM, Liu ZS. Down-regulation of Risa improves podocyte injury by enhancing autophagy in diabetic nephropathy. Mil Med Res. 2022;9:23. doi:10.1186/s40779-022-00385-0.
   PubMed Web of Science ®Google Scholar
• Li XZ, Jiang H, Xu L, Liu YQ, Tang JW, Shi JS, Yu XJ, Wang X, Du L, Lu Q, et al. Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3beta signaling pathway. Biochem Pharmacol. 2021;192:114675. doi:10.1016/j.bcp.2021.114675.
   PubMed Web of Science ®Google Scholar
• Tagawa A, Yasuda M, Kume S, Yamahara K, Nakazawa J, Chin-Kanasaki M, Araki H, Araki S, Koya D, Asanuma K, et al. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy. Diabetes. 2016;65:755–767. doi:10.2337/db15-0473.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Guo M, Li Y, Shen M, Kong D, Shao J, Ding H, Tan S, Chen A, Zhang F, et al. RNA-binding protein ZFP36/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells. Autophagy. 2020;16:1482–1505. doi:10.1080/15548627.2019.1687985.
   PubMed Web of Science ®Google Scholar
• Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, Coppes RP, Engedal N, Mari M, Reggiori F. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14:1435–1455. doi:10.1080/15548627.2018.1474314.
   PubMed Web of Science ®Google Scholar
• Jin J, Gong J, Zhao L, Zhang H, He Q, Jiang X. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux. J Diabetes. 2019;11:826–836. doi:10.1111/1753-0407.12914.
   PubMed Web of Science ®Google Scholar
• Schievenbusch S, Strack I, Scheffler M, Nischt R, Coutelle O, Hösel M, Hallek M, Fries JWU, Dienes H-P, Odenthal M, et al. Combined paracrine and endocrine AAV9 mediated expression of hepatocyte growth factor for the treatment of renal fibrosis. Mol Ther. 2010;18:1302–1309. doi:10.1038/mt.2010.71.
   PubMed Web of Science ®Google Scholar
• Chen W, Peng R, Sun Y, Liu H, Zhang L, Peng H, Zhang Z. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy via the miR-449a/b/Trim11/Mek signaling pathway. Faseb J. 2019;33:11492–11506. doi:10.1096/fj.201900522R.
   PubMed Web of Science ®Google Scholar
• Ferrè F, Colantoni A, Helmer-Citterich M. Revealing protein-lncRNA interaction. Brief Bioinform. 2016;17:106–116. doi:10.1093/bib/bbv031.
   PubMed Web of Science ®Google Scholar
• Liang Y, Chen X, Wu Y, Li J, Zhang S, Wang K, Guan X, Yang K, Bai Y. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Cell Death Differ. 2018;25:1980–1995. doi:10.1038/s41418-018-0084-9.
   PubMed Web of Science ®Google Scholar
• Guo J, Lei M, Cheng F, Liu Y, Zhou M, Zheng W, Zhou Y, Gong R, Liu Z. RNA-binding proteins tristetraprolin and human antigen R are novel modulators of podocyte injury in diabetic kidney disease. Cell Death Dis. 2020;11:413. doi:10.1038/s41419-020-2630-x.
   PubMed Web of Science ®Google Scholar
• Guo J, Li J, Zhao J, Yang S, Wang L, Cheng G, Liu D, Xiao J, Liu Z, Zhao Z. MiRNA-29c regulates the expression of inflammatory cytokines in diabetic nephropathy by targeting tristetraprolin. Sci Rep. 2017;7:2314. doi:10.1038/s41598-017-01027-5.
   PubMed Web of Science ®Google Scholar
• Yang T, Ren C, Lu C, Qiao P, Han X, Wang L, Wang D, Lv S, Sun Y, Yu Z. Phosphorylation of HSF1 by PIM2 induces PD-L1 expression and promotes tumor growth in breast cancer. Cancer Res. 2019;79:5233–5244. doi:10.1158/0008-5472.CAN-19-0063.
   PubMed Web of Science ®Google Scholar
• Park J, Rah S-Y, An HS, Lee JY, Roh GS, Ryter SW, Park JW, Yang CH, Surh Y-J, Kim U-H, et al. Metformin-induced TTP mediates communication between Kupffer cells and hepatocytes to alleviate hepatic steatosis by regulating lipophagy and necroptosis. Metabolism. 2023;141:155516. doi:10.1016/j.metabol.2023.155516.
   PubMed Web of Science ®Google Scholar
• Ngoc LV, Wauquier C, Soin R, Bousbata S, Twyffels L, Kruys V, Gueydan C. Rapid proteasomal degradation of posttranscriptional regulators of the TIS11/tristetraprolin family is induced by an intrinsically unstructured region independently of ubiquitination. Mol Cell Biol. 2014;34:4315–4328. doi:10.1128/MCB.00643-14.
   PubMed Web of Science ®Google Scholar
• Zhao M, Zhang Y, Jiang Y, Wang K, Wang X, Zhou D, Wang Y, Yu R, Zhou X. YAP promotes autophagy and progression of gliomas via upregulating HMGB1. J Exp Clin Cancer Res. 2021;40:99. doi:10.1186/s13046-021-01897-8.
   PubMed Web of Science ®Google Scholar
• Feng B, Yang F, Liu J, Sun Q, Meng R, Zhu D. Amelioration of diabetic kidney injury with dapagliflozin is associated with suppressing renal HMGB1 expression and restoring autophagy in obese mice. J Diabetes Complications. 2023;37:108409. doi:10.1016/j.jdiacomp.2023.108409.
   PubMed Web of Science ®Google Scholar
• Feng L, Liang L, Zhang S, Yang J, Yue Y, Zhang X. HMGB1 downregulation in retinal pigment epithelial cells protects against diabetic retinopathy through the autophagy-lysosome pathway. Autophagy. 2022;18:320–339. doi:10.1080/15548627.2021.1926655.
   PubMed Web of Science ®Google Scholar
• Wang H, Chen Y, Guo J, Shan T, Deng K, Chen J, Cai L, Zhou H, Zhao Q, Jin S, et al. Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1. Sci Rep. 2018;8:7080. doi:10.1038/s41598-018-25443-3.
   PubMed Web of Science ®Google Scholar
• Kim YH, Kwak MS, Lee B, Shin JM, Aum S, Park IH, Lee MG, Shin JS. Secretory autophagy machinery and vesicular trafficking are involved in HMGB1 secretion. Autophagy. 2021;17:2345–2362. doi:10.1080/15548627.2020.1826690.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhou H, Zheng H, Zhou X, Shen G, Teng X, Liu X, Zhang J, Wei X, Hu Z, et al. Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin in fl ammation. Autophagy. 2021;17:529–552. doi:10.1080/15548627.2020.1725381.
   PubMed Web of Science ®Google Scholar
• He M, Chu T, Wang Z, Feng Y, Shi R, He M, Feng S, Lu L, Cai C, Fang F, et al. Inhibition of macrophages inflammasome activation via autophagic degradation of HMGB1 by EGCG ameliorates HBV-induced liver injury and fibrosis. Front Immunol. 2023;14:1147379. doi:10.3389/fimmu.2023.1147379.
   PubMed Web of Science ®Google Scholar
• Zhang Y. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-beta1 pathway. Biosci Rep. 2021;41:BSR20203131. doi:10.1042/BSR20203131.
   Web of Science ®Google Scholar
• Gao D, Wang S, Lin Y, Sun Z. In vivo AAV delivery of glutathione reductase gene attenuates anti-aging gene klotho deficiency-induced kidney damage. Redox Biol. 2020;37:101692. doi:10.1016/j.redox.2020.101692.
   PubMed Web of Science ®Google Scholar